Vous êtes ici

Curriculum Vitae

Expand | Collapse

Emmanouil Sinakos

Assistant Professor, School of Medicine

Personal Information

- 2310992940
esinakos@auth.gr
www.sinakos.gr
Γνωστικό Αντικείμενο:
Παθολογία-Ηπατολογία
Επιστημονική Ειδίκευση: Ιατρική

Education

Προπτυχιακές Σπουδές

1996	Ιατρός Ιατρική Α.Π.Θ. Greece

Μεταπτυχιακές Σπουδές

2004	Παθολόγος Greece

Διδακτορικό Δίπλωμα

2007	Δ.Δ. Ιατρική Α.Π.Θ. Greece

Μετεκπαίδευση

Research Fellow, Mayo Clinic, Rochester Minessota, USA 2009-2010

Course Work

Courses of Winter semester of 2016–17 academic year

	TMĪMA IATRIKĪS
ΙΑ0319	Internal Medicine
ΙΑ0321	Internal Medicine II

Courses of Spring semester of 2016–17 academic year

	TMĪMA IATRIKĪS
ΙΑ0319	Internal Medicine
ΙΑ0320	Internal Medicine I

Research Projects

2015–2017	Ομιλίες - συμβουλευτικές υπηρεσίες στην ηπατολογία.
2015–2015	Δεδομένα ασφάλειας και αποτελεσματικότητας με Simeprevir στη διπλή θεραπεία
2015–2015	Η θέση του Everolimus σαν τη νέα δυνητική θεραπεία εκλογής στη Μεταμόσχευση Ήπατος
2014–2015	Συμβουλευτική επιτροπή με θέμα "Νέα δεδομένα στην Ηπατίτιδα C"

Publications

2012

Gigi Eleni, Sykia A, Sinakos Emmanouil, Koumerkeridis G, Raptopoulou-Gigi Maria, Bellou A-L, Mougiou D, Orfanou-Koumerkeridou Eleni, Vrettou Eleni (2012). Virologic response and resistance to lamivudine in patients with chronic hepatitis B: a ten-year retrospective analysis. Hippokratia. vol.16 no.4 p.342-346.
Sinakos Emmanouil, Vlachaki Efthymia, Tsapas Apostolos (2012). Safety of deferasirox in sickle cell disease patients with co-existing liver impairment. British Journal of Haematology.

2010

Rijckborst V, Hansen BE, Cakaloglu Y, Ferenci P, Tabak F, Akdogan M, Simon K, Akarca US, Flisiak R, Verhey E, Van Vuuren AJ, et al (2010). Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels. Journal of Hepatology. vol.52 no.2 p.454-461.
Sinakos Emmanouil, Gigi Eleni, Lalla Thalia, Bellou Aristea-Lia, Sykja Albana, Orfanou-Koumerkeridou Eleni, Vrettou Eleni, Tsapas Apostolos, Raptopoulou-Gigi Maria (2010). Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment. Hippokratia. vol.14 no.2 p.122-125.

2009

Sykia A, Gigi Eleni, Sinakos Emmanouil, Bibashi E, Bellou A, Raptopoulou-Gigi Maria (2009). Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a and ribavirin. Journal of Gastrointestinal & Liver Diseases. vol.18 no.1 p.118-119.

2008

Gigi Eleni, Raptopoulou-Gigi Maria, Kalogeridis A, Mansiou A, Orfanou-Koumerkeridou Eleni, Vrettou Eleni, Sinakos Emmanouil, Tsapas Apostolos (2008). Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self-limited disease. Journal of Viral Hepatitis. vol.15 no.2 p.145-154.

2007

Gigi Eleni, Sinakos Emmanouil, Lalla Th, Vrettou Eleni, Orfanou-Koumerkeridou Eleni, Raptopoulou-Gigi Maria (2007). Treatment of intravenous drug users with chronic hepatitis C: Treatment response, compliance and side effects. Hippokratia. vol.11 no.4 p.196-198.
Gigi Eleni, Lalla Thalia, Orfanou-Koumerkeridou Eleni, Sinakos Emmanouil, Vrettou Eleni, Raptopoulou-Gigi Maria (2007). Long Term Follow-Up of a Large Cohort of Inactive HBsAg (+) HBeAg (-)anti-HBe (+) Carriers in Greece. Journal of Gastrointestinal & Liver Diseases. vol.16 no.1 p.19-22.

2006

Raptopoulou-Gigi Maria, Sinakos Emmanouil, Orfanou-Koumerkeridou Eleni, Lalla Thalia, Gigi Eleni (2006). Monitoring of patients with sustained virological response treated with standard or pegylated interferon in combination with ribavirin for chronic hepatitis C. Hippokratia. vol.10 no.1 p.32-34.

2015

Tzioufa-Asimakopoulou Valentini, Raptopoulou-Gigi Maria, Sinakos Emmanouil, Bobos M, Orfanou-Koumerkeridou Eleni, Lalla Th, Gigi Eleni, Vrettou Eleni (2015). Steatosis in chronic hepatitis C. Correlation with specific HCV genotype and metabolic co-factors. 20th European Congress of Pathology. France - Paris.

Mis à jour: 2017-08-07